Craig Eugene Caufield
Princeton University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Craig Eugene Caufield.
Tetrahedron Letters | 1993
Robert J. Steffan; Robert M. Kearney; David Cheng Hu; Amedeo Arturo Failli; Jerauld S. Skotnicki; Robert A. Schiksnis; James F. Mattes; Kelvin W. Chan; Craig Eugene Caufield
Abstract The base catalyzed degradation of rapamycin was re-examined and a sequence of steps involving β-elimination, retro-aldol cleavage and benzilic acid rearrangement occur leading to several new products.
Tetrahedron Letters | 2003
Alexander Alexei Greenfield; John A. Butera; Craig Eugene Caufield
A convenient synthetic methodology amenable for rapid synthesis of differentially functionalized terphenyls is described. Orthogonality requirements for the incorporation of phenoxy acetic acid and carboxamide function have been satisfied by utilization of hydroxyethoxy group as a precursor of the acid. Highly efficient and universal procedures have been developed for acid and amide formation.
Tetrahedron Letters | 1994
Alexander A. Grinfeld; Craig Eugene Caufield; Robert A. Schiksnis; James F. Mattes; Kelvin W. Chan
Abstract Rapamycin rapidly undergoes demethoxylation at C-7 in the presence of Lewis acids (BF 3 ·Et 2 O, SnCl 4 etc.) to give a highly stabilized carbocation. This intermediate gives a tetraene or is trapped by nucleophiles to give functionalized trienes. Several examples of the substitution reaction and elaboration of the reaction scheme are reported.
Annual Reports in Medicinal Chemistry | 1990
Craig Eugene Caufield; John H. Musser
Publisher Summary The emergence of new novel chemical classes of macrocyclic immunomodulators may provide a greater understanding of the factors that control the immune system. The prototype for such emerging class of agents is cyclosporin A (CsA). This chapter discusses the mechanism of action of CsA with a summary of the chemistry; in vitro and in vivo immunopharmacology and the mechanism of action of the newer macrocyclic immunomodulators, such as FK-506, rapamycin, and didemnins. FK-506, RPM, and didemnin B (DB) may be found to be safer and more efficacious agents for transplantation rejection and autoimmune disease than CsA. FK-506 and CsA both act by inhibiting the production of growth promoting lymphokines, although FK-506 is effective at much lower doses. RPM, although structurally similar to FK-506, acts by inhibiting the response of T cells to lymphokines. The mechanism of the action of DB remains unknown, but seems to be more antiproliferative than either FK-506 or RPM. The importance and relevance of immunophilins needs to be delineated, but they may have a role in immunological signal transduction. In addition or alternatively, the immunophilins may be involved in the renal or vascular toxicity observed with this emerging class of novel macrocyclic immunomodulatory agents.
Journal of Computational Chemistry | 1990
Fariborz Mohamadi; Nigel G. J. Richards; Wayne C. Guida; Rob M. J. Liskamp; Mark Lipton; Craig Eugene Caufield; George Chang; Thomas Hendrickson; W. Clark Still
Archive | 1991
Craig Eugene Caufield; Amedeo Arturo Failli; Robert J. Steffan
Archive | 1990
Craig Eugene Caufield; John H. Musser; James Michael Rinker
Archive | 1991
Amedeo Arturo Failli; Craig Eugene Caufield; Robert J. Steffan
Archive | 1992
Craig Eugene Caufield; John H. Musser; Surendra Nath Sehgal
Archive | 1995
Craig Eugene Caufield; Alexander A. Grinfeld